Thoratec Corporation

Skip to content

Overview

THOR (Common Stock)
Price42.11Change0.00
Volume0% Change 0.00%
03/30/2015 4:00 p.m. ETPricing delayed 20 minutes

Thoratec is the world leader in mechanical circulatory support with the broadest product portfolio to treat the full range of clinical needs for patients suffering from advanced heart failure. The company's products include the HeartMate LVAS and Thoratec VAD, with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag and PediMag / PediVAS product lines. Thoratec is headquartered in Pleasanton, California. For more information, visit www.thoratec.com.

Recent News

More >>
DateTitle 
02/25/15Thoratec Announces Presentations At Investor Conferences For March 2015
PLEASANTON, Calif., Feb. 25, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences. On Wednesday, March 4, the company will participate in the Raymond James 36th Annual Institutional Investors Conference.  Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the compa... 
Printer Friendly Version
02/10/15Thoratec® Reports Fourth Quarter 2014 Results
- Revenue of $128.0 million for the fourth quarter of 2014 - GAAP net income per diluted share of $0.21, and non-GAAP net income per diluted share of $0.39 - Company establishes 2015 guidance for revenue of $450 million to $460 million and net income per diluted share of $0.60 to $0.70 on a GAAP basis and $1.10 to $1.20 on a non-GAAP basis PLEASANTON, Calif., Feb. 10, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support ... 
Printer Friendly Version
01/30/15Thoratec Presentation At Leerink Global Healthcare Conference To Be Webcast
PLEASANTON, Calif., Jan. 30, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Leerink Global Healthcare Conference on Thursday, February 12. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company beginning at 10:45 a.m., Eastern Standard Time (7:45 a.m., Pacific Standard Time).  ... 
Printer Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.